Novartis Investigative Site

Vitoria-Gasteiz, Araba 01009

0 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer, Relapsing Multiple Sclerosis

Studies at this site

• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling